SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nyman Eva 1949 ) "

Sökning: WFRF:(Nyman Eva 1949 )

  • Resultat 1-10 av 113
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Abel, Edvard, 1970, et al. (författare)
  • Impact on quality of life of IMRT versus 3-D conformal radiation therapy in head and neck cancer patients: A case control study
  • 2017
  • Ingår i: Advances in Radiation Oncology. - : Elsevier BV. - 2452-1094. ; 2:3, s. 346-353
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective The purpose of this study was to prospectively and longitudinally compare the health-related quality of life (HRQOL) outcomes between head and neck (HN) cancer patients treated with parotid-sparing intensity modulated radiation therapy (IMRT) and patients treated with 3-dimensional conventional radiation therapy (3D-CRT). Methods and materials Before and up to 12 months after treatment, HRQOL was recorded in patients with HN cancer who were referred to the Department of Oncology at Sahlgrenska University Hospital for curative IMRT. The study group's HRQOL was compared with a matched group of patients from previous descriptive HRQOL studies treated with 3D-CRT. Both groups' HRQOL was measured by the European Organization for Research and Treatment for Cancer QLQ-C30 and European Organization for Research and Treatment for Cancer QLQ-HN35 at 6 time points in the first year after diagnosis. Results Two hundred and seven patients were included, 111 treated with IMRT and 96 matched controls treated with 3D-CRT. Both groups' HRQOL deteriorated during and after treatment. Just after treatment, worse HRQOL scores were observed in the IMRT group regarding insomnia (38 vs 27; P = .032), appetite loss (64 vs 50; P = .019), senses (54 vs 41; P = .017), and coughing (39 vs 26, P = .009). At 12 months, however, significantly better HRQOL scores were observed in the IMRT group regarding problems with dry mouth (72 vs 62; P = .018), pain (28 vs 20; P = .018), sexuality (37 vs 23; P = .016), social contacts (10 vs 6; P = .026), cognitive functioning (79 vs 87; P = .0057), and financial difficulties (12 vs 20; P = .0019). Conclusions This study further supports the hypothesis that the introduction of IMRT has improved the long-term quality of life of HN cancer patients who have been treated with radiation therapy, but might cause more acute side effects. Longer follow-up is needed to study late complications.
  •  
2.
  • Berg, Malin, 1976, et al. (författare)
  • A randomized study comparing the nutritional effects of radiotherapy with cetuximab versus cisplatin in patients with advanced head and neck cancer
  • 2024
  • Ingår i: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. - 1043-3074 .- 1097-0347. ; 46:4, s. 760-771
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundHead and neck cancer (HNC) patients have a high risk of developing malnutrition. This randomized study aimed to compare the effect of weekly cisplatin or cetuximab combined with radiotherapy on weight loss at 3 months after treatment was started. Secondary outcomes were the prevalence of malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria, feeding tube dependence and health related quality of life from a nutritional perspective.MethodsPatients from the ARTSCAN III study with advanced HNC were assessed for weight, body composition, enteral tube dependence and selected quality-of-life scores (EORTC QLQ-C30 and QLQ-H&N35) at diagnosis and 6 weeks 3, 6 and 12 months after treatment initiation.ResultsOf the 80 patients, 38 and 42 were randomized to receive cetuximab and cisplatin treatment, respectively. There was no significant difference in weight loss at 3 months between the two study groups. However, the cetuximab group had significantly less weight loss, fewer enteral feeding tubes and better physical functioning at the end of treatment but more pain-related problems 3 months after treatment initiation. No differences between the groups were found at 6 and 12 months. The prevalence of malnutrition was not significantly different at any time point.ConclusionThe hypothesized benefit of concomitant treatment with cetuximab over cisplatin regarding the prevalence of malnutrition was not supported by this study.
  •  
3.
  • Nyman, Eva, 1949- (författare)
  • Bornholm, Birgitta och burgunderna
  • 2002
  • Ingår i: Ortnamnssällskapets i Uppsala årsskrift.. - Uppsala : Ortnamnssällskapet i Uppsala. - 0473-4351. ; , s. 5-18
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
4.
  • Nyman, Eva, 1949- (författare)
  • Das -s-Suffix in nordischen Ortsnamen.
  • 2004
  • Ingår i: Suffixbildungen in alten Ortsnamen. Akten eines internationalen Symposiums in Uppsala 14.-16- Mai 2004. - Uppsala : Kungl. Gustav Adolfs Akademien. - 9185352578 ; , s. 61-73, s. 61-73
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
5.
  • Nyman, Eva, 1949- (författare)
  • De norska ortnamnen Skaun (Skogn) och det svenska Skön
  • 2012
  • Ingår i: Germansk filologi og norske ord. Festskrift til Harald Bjorvand på 70-årsdagen den 30. juli 2012. - Oslo : Novus Forlag. - 9788270997008 ; , s. 141-156
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
6.
  • Nyman, Eva, 1949- (författare)
  • Det bohuslänska sockennamnet Harestad.
  • 1992
  • Ingår i: Sakrale navne. - Uppsala : NORNA-förlaget. - 917276046X ; , s. 199-219
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
7.
  • Nyman, Eva, 1949- (författare)
  • Det västgötska sockennamnet Undenäs
  • 1990
  • Ingår i: Allan Rostvik den 22 mars 1990. - Uppsala : Ortnamnsarkivet i Uppsala. - 9179709664 ; , s. 101-111
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
8.
  • Nyman, Eva, 1949- (författare)
  • Det västmanländska sockennamnet Sevalla.
  • 1987
  • Ingår i: Namn och bygd. - Stockholm : Almqvist & Wiksell International. - 0077-2704. ; 75:1-4, s. 100-116
  • Tidskriftsartikel (refereegranskat)
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 113

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy